Literature DB >> 11044222

Salutary role for angiotensin in partial urinary tract obstruction.

H Fujinaka1, Y Miyazaki, T Matsusaka, H Yoshida, A B Fogo, T Inagami, I Ichikawa.   

Abstract

BACKGROUND: In the neonatal period, angiotensin II (Ang II) is up-regulated and induces a timely development of the renal pelvis and ureteral peristalsis, thereby protecting the kidney from hydronephrosis. We tested the possibility that in adulthood, Ang II may act salutarily on the kidney structure during partial urinary tract obstruction by inducing adaptive changes in the peristaltic machinery.
METHODS: Adult male Sprague-Dawley rats were subjected to partial unilateral ureteral obstruction (UUO) and divided into two groups, that is, those treated with (group L, N = 21) and those without (group C, N = 21) an angiotensin type 1 (AT1) receptor antagonist (losartan). Control animals were sham operated (N = 10). Rats were sacrificed either at day 7 or day 14.
RESULTS: The degree of hydronephrosis determined morphometrically was significantly more severe in group L than group C at both day 7 and day 14, indicating that Ang II inhibition accentuated hydronephrosis. The measurement of upstream pressure within the partially ligated ureter in vivo revealed that losartan significantly attenuates the frequency of ureteral peristaltic activities. In in vitro studies using ureteral strips harvested from normal adult Sprague-Dawley rats (N = 10), Ang II (10(-8) mol/L) was shown to augment contraction, which was completely inhibited by losartan (10(-6) mol/L).
CONCLUSIONS: Ang II has a salutary effect of protecting kidneys from hydronephrosis during partial ureteral obstruction through its ability to augment ureteral peristalsis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044222     DOI: 10.1111/j.1523-1755.2000.00374.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Local renin-angiotensin systems in the genitourinary tract.

Authors:  Craig Comiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-13       Impact factor: 3.000

Review 2.  Genetic and developmental basis for urinary tract obstruction.

Authors:  Feng Chen
Journal:  Pediatr Nephrol       Date:  2008-12-16       Impact factor: 3.714

Review 3.  Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells.

Authors:  Yohei Maeshima
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

4.  Plumbing the depths of urinary tract obstruction by using murine models.

Authors:  Feng Chen
Journal:  Organogenesis       Date:  2009-01       Impact factor: 2.500

5.  Inducible nitric oxide synthase modulates hydronephrosis following partial or complete unilateral ureteral obstruction in the neonatal mouse.

Authors:  Kee Hwan Yoo; Barbara A Thornhill; Michael S Forbes; Robert L Chevalier
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-04

6.  Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter.

Authors:  Slobodan M Jankovic; Dobrivoje Stojadinovic; Miroslav Stojadinovic; Snezana V Jankovic; Janko M Djuric; Isidora Stojic; Marina Kostic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

7.  The role of apelin on the alleviative effect of Angiotensin receptor blocker in unilateral ureteral obstruction-induced renal fibrosis.

Authors:  Masashi Nishida; Yasuko Okumura; Tatsujiro Oka; Kentaro Toiyama; Seiichiro Ozawa; Toshiyuki Itoi; Kenji Hamaoka
Journal:  Nephron Extra       Date:  2012-03-07

Review 8.  Obstructive renal injury: from fluid mechanics to molecular cell biology.

Authors:  Alvaro C Ucero; Sara Gonçalves; Alberto Benito-Martin; Beatriz Santamaría; Adrian M Ramos; Sergio Berzal; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  Open Access J Urol       Date:  2010-04-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.